Gualen, Baby Girl .
HRN: 26-80-29 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/08/2025
AMPICILLIN 250MG (VIAL)
03/08/2025
03/15/2025
IV
80
Q12H
PREMATURITY/NEONATAL SEPSIS
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes